CD63 and nasopharyngeal carcinoma: Therefore, we designed a co‐culture system of high and low metastatic potential NPC cells in which the highly metastatic NPC cells (upper chamber) were transfected with pMcherry‐CD63 plasmid to label the EVs marker CD63 (Figure 2a).